Breno Oliveira Almeida

Breno Oliveira Almeida

Auto-generated profile, based on publicly available information

Breno Oliveira Almeida

Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
GPGuy F A Prado
Guy F A Prado
PBPablo J. Blanco
Pablo J. Blanco
CBCarlos A. Bulant
Carlos A. Bulant
GAGonzalo D. Ares
Gonzalo D. Ares
JMJose Mariani
Jose Mariani
PLPedro A. Lemos
Pedro A. Lemos

23 June 2023 in Renal Failure
Verified
Journal Article
Open access
GPGuy F A Prado
Guy F A Prado
SGStefano Garzon
Stefano Garzon
JMJose Mariani
Jose Mariani
ACAdriano Caixeta
Adriano Caixeta
BABreno O. Almeida
Breno O. Almeida
PLPedro A. Lemos
Pedro A. Lemos
Candidates for transcatheter aortic valve implantation (TAVI) are currently evaluated using computed tomography angiography and invasive cardiac catheterization as an essential part of case selection and pre-procedure interventional planning. However, both imaging methods utilize iodinated agents, which may cause contrast-induced nephropathy, particularly in patients with baseline renal dysfunction. This study aimed to describe a zero-contrast imaging protocol for pre-TAVI evaluation in patients with advanced renal impairment. The pre-TAVI zero-contrast scheme consisted of the following multi-modality combinations: (1) gadolinium-free magnetic resonance imaging (three-dimensional navigator-echo with electrocardiogram-gated steady-state free-precession series); (2) iodinated-free multislice computed tomography electrocardiogram-gated; (3) lower limb arterial duplex scan ultrasound; and (4) transesophageal echocardiography. Ultimately, TAVI was performed for those deemed good candidates, and contrast was allowed during the intervention; however, operators were strongly advised to utilize the least volume possible of iodinated agents. This pilot survey included ten patients with symptomatic aortic stenosis and renal dysfunction who underwent zero-contrast multi-modality imaging. All the patients ultimately underwent TAVI. The intervention was successful in all cases, without ≥ moderate residual aortic regurgitation, prosthesis embolization, annulus rupture, major vascular complications, stroke, or death during index hospitalization. The creatinine clearance remained stable throughout the observation period (baseline: 26.85 ± 12.55 mL/min; after multi-modality imaging: 26.76 ± 11.51 mL/min; post-TAVI at discharge: 29.84 ± 13.98 mL/min; p = 0.3 all). The proposed contrast-free imaging protocol appears to be a promising clinical tool for pre-TAVI evaluation in patients with severe renal dysfunction.

23 October 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
SGStefano Garzon
Stefano Garzon
LPLuiz Fernando Muniz Pinheiro
Luiz Fernando Muniz Pinheiro
FBFelipe Mateus Bezerra
Felipe Mateus Bezerra
GPGuy F A Prado
Guy F A Prado
JMJosé Mariani
José Mariani
PLPedro Alves Lemos
Pedro Alves Lemos
Highlights ■ Optical coherence tomography enables in vivo characterization of inflammatory activity within coronary plaques. ■ Thin-cap fibroatheromas demonstrate greater macrophage accumulation than non-thin-cap fibroatheromas. ■ Neovascularization is more frequent and quantitatively greater in thin-cap fibroatheromas. ■ The combined burden of macrophages and neovessels provides predictive value for plaque vulnerability. ABSTRACT Objective: The aim of the present study is to assess whether the intensity of local inflammation relates to the presence of thin-cap fibroatheromas. Methods: Retrospective, single-center study of patients